应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MRNA Moderna, Inc.
耶稣受难日休市 03-28 16:00:00 EDT
106.56
-4.03
-3.64%
盘后
106.65
+0.09
+0.08%
19:59 EDT
最高
112.00
最低
105.95
成交量
396.03万
今开
111.10
昨收
110.59
日振幅
5.47%
总市值
408.00亿
流通市值
368.23亿
总股本
3.83亿
成交额
4.26亿
换手率
1.15%
流通股本
3.46亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Moderna从黑石获得7.5亿美元资金,用于研发流感疫苗
老虎资讯综合 · 03-27 20:47
Moderna从黑石获得7.5亿美元资金,用于研发流感疫苗
更新版 1-Moderna 从 Blackstone Life Sciences 获得 7.5 亿美元,用于开发流感疫苗
Reuters · 03-27 18:59
更新版 1-Moderna 从 Blackstone Life Sciences 获得 7.5 亿美元,用于开发流感疫苗
BUZZ-Moderna 因与 Blackstone Life Sciences 达成 7.5 亿美元融资协议而上涨
Reuters · 03-27 18:50
BUZZ-Moderna 因与 Blackstone Life Sciences 达成 7.5 亿美元融资协议而上涨
Moderna 从 Blackstone Life Sciences 获得 7.5 亿美元资金,用于开发流感疫苗
Reuters · 03-27 18:30
Moderna 从 Blackstone Life Sciences 获得 7.5 亿美元资金,用于开发流感疫苗
莫德纳盘中异动 急速上涨5.04%
自选股智能写手 · 03-26
莫德纳盘中异动 急速上涨5.04%
BUZZ-生物技术公司因 2024 年收入预期不乐观而下跌
Reuters · 03-20
BUZZ-生物技术公司因 2024 年收入预期不乐观而下跌
期权大单 | 比特币首破7.2万美元!MARA看涨期权押注超七成;甲骨文迎来高光时刻,期权成交量激增超五倍
老虎资讯综合 · 03-12
期权大单 | 比特币首破7.2万美元!MARA看涨期权押注超七成;甲骨文迎来高光时刻,期权成交量激增超五倍
嗡嗡声--美国股票走势-Acelyrin、Endeavour Silver、B2Gold
Reuters · 03-12
嗡嗡声--美国股票走势-Acelyrin、Endeavour Silver、B2Gold
BUZZ-分析师称,Moderna因与默克公司合作开展新的皮肤癌治疗试验而上涨
Reuters · 03-11
BUZZ-分析师称,Moderna因与默克公司合作开展新的皮肤癌治疗试验而上涨
美股异动 | Moderna大涨近11%,领涨标普500指数成分股
智通财经 · 03-11
美股异动 | Moderna大涨近11%,领涨标普500指数成分股
莫德纳盘中异动 早盘大幅上涨5.07%报108.25美元
自选股智能写手 · 03-11
莫德纳盘中异动 早盘大幅上涨5.07%报108.25美元
莫德纳涨0.52% 股价突破100美元大关
自选股智能写手 · 03-08
莫德纳涨0.52% 股价突破100美元大关
莫德纳盘中异动 大幅拉升5.03%
自选股智能写手 · 03-02
莫德纳盘中异动 大幅拉升5.03%
Moderna, Inc.盘中异动 快速跳水5.00%报92.61美元
自选股智能写手 · 03-01
Moderna, Inc.盘中异动 快速跳水5.00%报92.61美元
健康巡讲:对 mRNA COVID 疫苗的抗体反应比以前认为的更持久
Reuters · 02-28
健康巡讲:对 mRNA COVID 疫苗的抗体反应比以前认为的更持久
Moderna Inc盘中异动 早盘快速跳水5.02%报91.62美元
自选股智能写手 · 02-26
Moderna Inc盘中异动 早盘快速跳水5.02%报91.62美元
美股异动 | 遭汇丰银行下调评级 Moderna(MRNA.US)跌超4%
智通财经 · 02-26
美股异动 | 遭汇丰银行下调评级 Moderna(MRNA.US)跌超4%
Moderna(MRNA)跌4.62% 汇丰银行下调其评级至减持
金吾财讯 · 02-26
Moderna(MRNA)跌4.62% 汇丰银行下调其评级至减持
美国研究综述-Elf Beauty、Moderna、Zscaler
Reuters · 02-26
美国研究综述-Elf Beauty、Moderna、Zscaler
加载更多
公司概况
公司名称:
Moderna, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸(信使核糖核酸)医学领域的领导者。通过在科学、技术和健康的交叉领域工作十多年,该公司以前所未有的速度和效率开发出药物,包括最早和最有效的新冠疫苗之一。该公司的mRNA平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和由Moderna价值观和思维模式驱动的全球化团队,以负责任的方式改变人类健康的未来,该公司努力通过mRNA药物向人们传递尽可能大的影响。
发行价格:
--
{"stockData":{"symbol":"MRNA","market":"US","secType":"STK","nameCN":"Moderna, Inc.","latestPrice":106.56,"timestamp":1711656000000,"preClose":110.59,"halted":0,"volume":3960279,"hourTrading":{"tag":"盘后","latestPrice":106.65,"preClose":106.56,"latestTime":"19:59 EDT","volume":197777,"amount":21075934.4854,"timestamp":1711670363432},"delay":0,"floatShares":345557196,"shares":382879612,"eps":-12.340314,"marketStatus":"耶稣受难日休市","marketStatusCode":7,"change":-4.03,"latestTime":"03-28 16:00:00 EDT","open":111.1,"high":112,"low":105.95,"amount":426095565.85449,"amplitude":0.054707,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-12.340314,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1711958400000},"adr":0,"listingDate":1544158800000,"adjPreClose":110.59,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":111.11,"preClose":110.59,"latestTime":"09:29 EDT","volume":13228,"amount":1466374.99236,"timestamp":1711632599999},"postHourTrading":{"tag":"盘后","latestPrice":106.65,"preClose":106.56,"latestTime":"19:59 EDT","volume":197777,"amount":21075934.4854,"timestamp":1711670363432},"volumeRatio":1.1937362832149507,"optionData":{"bulkOrders":[{"symbol":"MRNA","call":true,"expireDate":1711598400000,"strike":"109.0","timestamp":1711650030445,"price":0.07000000029802322,"volume":2130,"amount":14910,"type":"+"},{"symbol":"MRNA","call":true,"expireDate":1712289600000,"strike":"111.0","timestamp":1711650030428,"price":1.1100000143051147,"volume":2130,"amount":236430,"type":"-"}]}},"requestUrl":"/m/hq/s/MRNA","defaultTab":"news","newsList":[{"id":"1195638205","title":"Moderna从黑石获得7.5亿美元资金,用于研发流感疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1195638205","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1195638205?lang=zh_cn&edition=full","pubTime":"2024-03-27 20:47","pubTimestamp":1711543623,"startTime":"0","endTime":"0","summary":"Moderna计划今年向监管机构提交申请。","market":"us","thumbnail":"https://static.tigerbbs.com/82c5415f2f95d1aa45f7d808f8dae731","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/82c5415f2f95d1aa45f7d808f8dae731"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"gpt_icon":0},{"id":"2422964100","title":"更新版 1-Moderna 从 Blackstone Life Sciences 获得 7.5 亿美元,用于开发流感疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2422964100","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422964100?lang=zh_cn&edition=full","pubTime":"2024-03-27 18:59","pubTimestamp":1711537155,"startTime":"0","endTime":"0","summary":"作为协议的一部分,Blackstone Life Sciences 将获得商业里程碑付款和低个位数的版税,COVID-19 疫苗生产商表示。Moderna 股价在盘前交易中上涨超过 2%。Moderna 计划今年向监管机构提交申请。其 RSV 疫苗预计将于今年在美国上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422961210","title":"BUZZ-Moderna 因与 Blackstone Life Sciences 达成 7.5 亿美元融资协议而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2422961210","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422961210?lang=zh_cn&edition=full","pubTime":"2024-03-27 18:50","pubTimestamp":1711536602,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 3月27日 - ** 疫苗制造商 Moderna 的 股价盘前上涨 2.3% 至 109.85 美元 ** 公司与 Blackstone 的 生命科学投资平台达成 7.5 亿美元的融资协议,以开发 mRNA 流感疫苗 (link) ** 作为协议的一部分,Blackstone Life Sciences 将获得商业里程碑付款和低个位数百分比的特许权使用费** Moderna 还计划在 2024 年投入约 45 亿美元用于研发** 截至上次收盘,股价累计上涨 8","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422966008","title":"Moderna 从 Blackstone Life Sciences 获得 7.5 亿美元资金,用于开发流感疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=2422966008","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2422966008?lang=zh_cn&edition=full","pubTime":"2024-03-27 18:30","pubTimestamp":1711535414,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透社3月27日 - Moderna 周三表示,已与私募股权公司 Blackstone 的 生命科学投资平台达成协议,将出资 7.5 亿美元开发其 mRNA 流感疫苗。这家 COVID-19 疫苗生产商称,作为协议的一部分,Blackstone Life Sciences 将获得商业里程碑付款和低个位数的版税。预计这笔资金将支持这家生物技术公司开发多种疫苗,以弥补以 Spikevax 品牌销售的 COVID 疫苗销量的下降。Moderna计划在2024年投入约45亿美元用于研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422573982","title":"莫德纳盘中异动 急速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422573982","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422573982?lang=zh_cn&edition=full","pubTime":"2024-03-26 03:56","pubTimestamp":1711396565,"startTime":"0","endTime":"0","summary":"北京时间2024年03月26日03时56分,莫德纳股票出现异动,股价大幅拉升5.04%。截至发稿,该股报110.74美元/股,成交量294.81万股,换手率0.77%,振幅4.54%。机构评级方面,在所有26家参与评级的机构中,50%的券商给予买入建议,38%的券商给予持有建议,12%的券商给予卖出建议。莫德纳股票所在的生物技术行业中,整体跌幅为0.09%。截至 2023 年中期,莫德纳拥有处于临床试验中的39个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403260356057a4eede5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403260356057a4eede5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420001721","title":"BUZZ-生物技术公司因 2024 年收入预期不乐观而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2420001721","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420001721?lang=zh_cn&edition=full","pubTime":"2024-03-20 23:19","pubTimestamp":1710947999,"startTime":"0","endTime":"0","summary":" 3月20日 - ** 在美国上市的德国生物技术公司 、 股价下跌6.7%,至87.8美元** BNTX认为 ,其2024年收入介于25亿欧元,31亿欧元低于分析师平均预期 的31.6亿欧元--LSEG** BNTX 第四季度营收为 14.8 亿欧元,低于预期的 18.3 亿欧元。** 其他 COVID-19 疫苗生产商,如 Moderna 股价下跌 2.5%,Novavax 下跌 3.9** 今年以来,BNTX 下跌 17.6%,MRNA 上升 2.8%,NVAX 下跌 ~1 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"1123852410","title":"期权大单 | 比特币首破7.2万美元!MARA看涨期权押注超七成;甲骨文迎来高光时刻,期权成交量激增超五倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1123852410","media":"老虎资讯综合","top":-1,"share":"https://www.laohu8.com/m/news/1123852410?lang=zh_cn&edition=full","pubTime":"2024-03-12 14:29","pubTimestamp":1710224959,"startTime":"0","endTime":"0","summary":"市值最大的比特币矿企Marathon Digital隔夜期权成交39.83万张合约,看涨期权占比77.6%。消息面上,比特币周一盘中涨超5000美元至7.2万美元上方,继上周五首次突破7万美元后又创历史新高。有美媒报道称,美国司法部已对该事故展开刑事调查。台积电收跌5.02%,连续两个交易日撤离收盘历史最高位149.20美元。","market":"hk","thumbnail":"https://static.tigerbbs.com/4f6ec6e99c0c8b9feb7f296b78c65a54","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/4f6ec6e99c0c8b9feb7f296b78c65a54"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"gpt_icon":1},{"id":"2418391850","title":"嗡嗡声--美国股票走势-Acelyrin、Endeavour Silver、B2Gold","url":"https://stock-news.laohu8.com/highlight/detail?id=2418391850","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2418391850?lang=zh_cn&edition=full","pubTime":"2024-03-12 02:18","pubTimestamp":1710181116,"startTime":"0","endTime":"0","summary":" * 个股异动的 Eikon 搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 3月11日 - 华尔街主要股指周一下滑,投资者在等待本周的关键通胀数据,在上周喜忧参半的就业报告之后,这些数据可能为美国联邦储备局的货币政策路径提供线索。美东时间14:02,道琼斯工业平均指数 上涨0.05%,报38,742.57点。标准普尔500指数 下跌0.16%,报5,115.28点;纳斯达克综合指数 下跌0.32%,报16,033.175点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2418345364","title":"BUZZ-分析师称,Moderna因与默克公司合作开展新的皮肤癌治疗试验而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2418345364","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2418345364?lang=zh_cn&edition=full","pubTime":"2024-03-11 23:20","pubTimestamp":1710170404,"startTime":"0","endTime":"0","summary":" 3月11日 - ** 疫苗生产商Moderna 股价上涨10.5%至113.76美元,为1月份以来最高价** 奥本海默分析师哈特杰-辛格认为,Moderna的股价上涨与美国临床试验登记处的一则通知有关:该公司将与默克公司一起,开始测试 它们的疫苗组合,用于治疗一种名为皮肤鳞状细胞癌(cutaneous squamous cell carcinoma(CSCC)的皮肤癌。** 默克公司的免疫疗法 Keytruda 和 Moderna 公司基于 MRNA 的疫苗也正在被评估用于治疗黑色素瘤和非小细胞肺癌。** MRNA 在过去 12 个月中下跌了 18.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2418936536","title":"美股异动 | Moderna大涨近11%,领涨标普500指数成分股","url":"https://stock-news.laohu8.com/highlight/detail?id=2418936536","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2418936536?lang=zh_cn&edition=full","pubTime":"2024-03-11 22:05","pubTimestamp":1710165914,"startTime":"0","endTime":"0","summary":"其他抗疫概念股同时上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1084800.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2418688243","title":"莫德纳盘中异动 早盘大幅上涨5.07%报108.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2418688243","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418688243?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:38","pubTimestamp":1710164322,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时38分,莫德纳股票出现波动,股价大幅拉升5.07%。截至发稿,该股报108.25美元/股,成交量43.3937万股,换手率0.11%,振幅5.18%。莫德纳股票所在的生物技术行业中,整体涨幅为0.52%。莫德纳公司简介:莫德纳是一家商业阶段的生物技术公司,成立于 2010 年,并于 2018 年 12 月进行首次公开募股。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证,该疫苗于 2020 年 12 月在美国获得批准。截至 2023 年中期,莫德纳拥有处于临床试验中的39个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031121384287e77c61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031121384287e77c61&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417270057","title":"莫德纳涨0.52% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2417270057","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417270057?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:36","pubTimestamp":1709908581,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时36分,莫德纳股票出现波动,股价急速上涨0.52%。截至发稿,该股报100.00美元/股,成交量12.4224万股,换手率0.03%,振幅1.08%。莫德纳股票所在的生物技术行业中,整体跌幅为0.28%。莫德纳公司简介:莫德纳是一家商业阶段的生物技术公司,成立于 2010 年,并于 2018 年 12 月进行首次公开募股。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证,该疫苗于 2020 年 12 月在美国获得批准。截至 2023 年中期,莫德纳拥有处于临床试验中的39个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030822362187e77524&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030822362187e77524&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416212436","title":"莫德纳盘中异动 大幅拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416212436","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416212436?lang=zh_cn&edition=full","pubTime":"2024-03-02 01:38","pubTimestamp":1709314739,"startTime":"0","endTime":"0","summary":"北京时间2024年03月02日01时38分,莫德纳股票出现波动,股价急速拉升5.03%。截至发稿,该股报96.88美元/股,成交量189.421万股,换手率0.50%,振幅5.13%。机构评级方面,在所有26家参与评级的机构中,50%的券商给予买入建议,38%的券商给予持有建议,12%的券商给予卖出建议。莫德纳股票所在的生物技术行业中,整体涨幅为2.53%。截至 2023 年中期,莫德纳拥有处于临床试验中的39个mRNA开发候选物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240302013900861da9ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240302013900861da9ca&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416509359","title":"Moderna, Inc.盘中异动 快速跳水5.00%报92.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416509359","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416509359?lang=zh_cn&edition=full","pubTime":"2024-03-01 04:52","pubTimestamp":1709239970,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日04时52分,Moderna, Inc.股票出现波动,股价大幅下跌5.00%。截至发稿,该股报92.61美元/股,成交量376.127万股,换手率0.98%,振幅4.70%。Moderna, Inc.股票所在的生物技术行业中,整体跌幅为1.87%。Moderna, Inc.公司简介:莫德纳是一家商业阶段的生物技术公司,成立于 2010 年,并于 2018 年 12 月进行首次公开募股。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证,该疫苗于 2020 年 12 月在美国获得批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240301045250861da3f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240301045250861da3f4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414387019","title":"健康巡讲:对 mRNA COVID 疫苗的抗体反应比以前认为的更持久","url":"https://stock-news.laohu8.com/highlight/detail?id=2414387019","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414387019?lang=zh_cn&edition=full","pubTime":"2024-02-28 04:37","pubTimestamp":1709066238,"startTime":"0","endTime":"0","summary":"mRNA COVID 疫苗不会很快失效纽约市的一项大型研究发现,Moderna 和辉瑞 /BioNTech 公司生产的mRNA COVID-19疫苗诱导的抗体反应是持久的,这对注射这些疫苗后免疫力迅速减退的观点提出了质疑。2020年4月至2023年3月期间,研究人员收集了501名医护人员的8000多份血液样本,研究了接种疫苗和感染后对病毒尖峰蛋白的抗体反应的变化情况。研究人员只分析了疫苗对原始冠状病毒全尖峰蛋白免疫反应的影响。他们没有评估对后来变种的抗体反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414122831","title":"Moderna Inc盘中异动 早盘快速跳水5.02%报91.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414122831","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414122831?lang=zh_cn&edition=full","pubTime":"2024-02-26 23:59","pubTimestamp":1708963164,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日23时59分,Moderna Inc股票出现波动,股价大幅跳水5.02%。截至发稿,该股报91.62美元/股,成交量172.597万股,换手率0.45%,振幅3.16%。Moderna Inc股票所在的生物技术行业中,整体跌幅为0.35%。Moderna Inc公司简介:莫德纳是一家商业阶段的生物技术公司,成立于 2010 年,并于 2018 年 12 月进行首次公开募股。该公司的 mRNA 技术通过其 COVID-19 疫苗迅速得到验证,该疫苗于 2020 年 12 月在美国获得批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623592487e732f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022623592487e732f2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414683913","title":"美股异动 | 遭汇丰银行下调评级 Moderna(MRNA.US)跌超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414683913","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2414683913?lang=zh_cn&edition=full","pubTime":"2024-02-26 23:47","pubTimestamp":1708962475,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周一,Moderna(MRNA.US)股价走低,截至发稿,该股跌超4%,报92.44美元。此前汇丰银行将Moderna的评级从“持有”下调至“减持”,并对Moderna的mRNA疫苗的整体市场潜力持谨慎态度,预计公司最高销售额为17亿美元,处于15亿至24亿美元的一致预期区间下限。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1077107.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2414836766","title":"Moderna(MRNA)跌4.62% 汇丰银行下调其评级至减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2414836766","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2414836766?lang=zh_cn&edition=full","pubTime":"2024-02-26 23:30","pubTimestamp":1708961419,"startTime":"0","endTime":"0","summary":"金吾财讯 | Moderna(MRNA)早盘震荡走低,截至发稿,跌4.62%,报92美元。汇丰银行将Moderna的评级从持有下调至减持,并对Moderna的mRNA疫苗的整体市场潜力持谨慎态度,预计公司最高销售额为17亿美元,处于15亿至24亿美元的一致预期区间下限。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/MmNlMmI2NWNjNWI2MzQ2MDk3MTI0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/MmNlMmI2NWNjNWI2MzQ2MDk3MTI0.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"273404","is_publish_highlight":false,"gpt_icon":0},{"id":"2414074158","title":"美国研究综述-Elf Beauty、Moderna、Zscaler","url":"https://stock-news.laohu8.com/highlight/detail?id=2414074158","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414074158?lang=zh_cn&edition=full","pubTime":"2024-02-26 15:57","pubTimestamp":1708934231,"startTime":"0","endTime":"0","summary":" 路透社2月26日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价,其中包括 Elf Beauty、Moderna 和 Zscaler。要点 * 精灵美容公司 :Piper Sandler将目标价从212美元上调至225美元 * Moderna :汇丰银行将目标价从持有下调至减持 * Zscaler Inc :摩根大通将目标价从212美元上调至240美元 以下是路透社周一报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.modernatx.com","stockEarnings":[{"period":"1week","weight":0.0237},{"period":"1month","weight":0.1077},{"period":"3month","weight":0.0715},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.2839},{"period":"ytd","weight":0.0715}],"compareEarnings":[{"period":"1week","weight":0.0017},{"period":"1month","weight":0.0318},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.2236},{"period":"1year","weight":0.3033},{"period":"ytd","weight":0.1005}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Moderna, Inc.于2016年7月22日根据特拉华州法律注册成立。该公司是信使核糖核酸(信使核糖核酸)医学领域的领导者。通过在科学、技术和健康的交叉领域工作十多年,该公司以前所未有的速度和效率开发出药物,包括最早和最有效的新冠疫苗之一。该公司的mRNA平台已使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和由Moderna价值观和思维模式驱动的全球化团队,以负责任的方式改变人类健康的未来,该公司努力通过mRNA药物向人们传递尽可能大的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.076025},{"month":2,"riseRate":0.333333,"avgChangeRate":0.021347},{"month":3,"riseRate":0.666667,"avgChangeRate":0.047414},{"month":4,"riseRate":0.6,"avgChangeRate":0.165158},{"month":5,"riseRate":0.6,"avgChangeRate":0.042487},{"month":6,"riseRate":0.4,"avgChangeRate":-0.009402},{"month":7,"riseRate":0.6,"avgChangeRate":0.134145},{"month":8,"riseRate":0.4,"avgChangeRate":-0.018231},{"month":9,"riseRate":0.6,"avgChangeRate":-0.013683},{"month":10,"riseRate":0.4,"avgChangeRate":-0.018111},{"month":11,"riseRate":1,"avgChangeRate":0.338665},{"month":12,"riseRate":0.4,"avgChangeRate":-0.066731}],"exchange":"NASDAQ","name":"Moderna, Inc.","nameEN":"Moderna, Inc."},"APP":{"userAgent":"claudebot","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.3","shortVersion":"4.22.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Moderna, Inc.,MRNA,Moderna, Inc.股票,Moderna, Inc.股票老虎,Moderna, Inc.股票老虎国际,Moderna, Inc.行情,Moderna, Inc.股票行情,Moderna, Inc.股价,Moderna, Inc.股市,Moderna, Inc.股票价格,Moderna, Inc.股票交易,Moderna, Inc.股票购买,Moderna, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Moderna, Inc.(MRNA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Moderna, Inc.(MRNA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}